Sign up to save your podcasts
Or
Share Neurology Today Highlight: antisense oligonucleotide therapy for variant of Batten disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Neurology Today Highlight: antisense oligonucleotide therapy for variant of Batten disease
Dr. Jason Crowell discusses Richard Robinson's article on an antisense oligonucleotide therapy for a rare variant of Batten Disease. To learn more, read the article "An Antisense Oligonucleotide Therapy Looks Promising for a Rare Form of Batten Disease" by Robinson in the June 20, 2019, issue of Neurology Today—available online at http://bit.ly/NT-Batten.
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Jason Crowell discusses Richard Robinson's article on an antisense oligonucleotide therapy for a rare variant of Batten Disease. To learn more, read the article "An Antisense Oligonucleotide Therapy Looks Promising for a Rare Form of Batten Disease" by Robinson in the June 20, 2019, issue of Neurology Today—available online at http://bit.ly/NT-Batten.
More shows like Neurology Minute
View all
JAMA Editors' Summary
129 Listeners
Neurology® Podcast
288 Listeners
NEJM This Week
324 Listeners
Practical Neurology Podcast
44 Listeners
JAMA Clinical Reviews
493 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
87 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
185 Listeners
Navigating Neuropsychology
340 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
366 Listeners
Continuum Audio
78 Listeners